These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 6311138
1. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma. Mazurenko NP, Gurtsevich VE, Stepina VN, Plakhov IV. Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138 [No Abstract] [Full Text] [Related]
2. [Humoral response to Epstein-Barr virus of patients with nasopharyngeal cancer and its use in the differential diagnosis of the disease]. Gurtsevich VE, Plakhov IV, Chuĭkina NA, Abdulin NA. Vestn Akad Med Nauk SSSR; 1984; (5):29-34. PubMed ID: 6331022 [No Abstract] [Full Text] [Related]
3. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma. Kottaridis SD, Goula I, Kiparissiadis P. Neoplasma; 1982; 29(3):327-31. PubMed ID: 6290911 [No Abstract] [Full Text] [Related]
4. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. N Engl J Med; 1989 Mar 16; 320(11):689-95. PubMed ID: 2537928 [Abstract] [Full Text] [Related]
5. Epstein-Barr virus-related serology in Hodgkin's disease. Henle W, Henle G. Natl Cancer Inst Monogr; 1973 May 16; 36():79-84. PubMed ID: 4355353 [No Abstract] [Full Text] [Related]
9. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease. Levine PH, Reisher JI. Natl Cancer Inst Monogr; 1973 May 16; 36():85-7. PubMed ID: 4355354 [No Abstract] [Full Text] [Related]
10. Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody. Lynn T, Tu S, Hirayama T, Kawamura A. Jpn J Exp Med; 1973 Apr 16; 43(2):135-44. PubMed ID: 4352112 [No Abstract] [Full Text] [Related]
11. Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma. Sam CK, Prasad U, Pathmanathan R. Eur J Surg Oncol; 1989 Aug 16; 15(4):357-60. PubMed ID: 2547665 [Abstract] [Full Text] [Related]
12. [Epstein-Barr virus capsid antigen (EB-VAC)-IgA antibody titer in splenectomized patients with Hodgkin's disease. A follow-up study]. Gunzer U, Nürnberger R. Verh Dtsch Ges Inn Med; 1974 Aug 16; 80():1619-23. PubMed ID: 4375897 [No Abstract] [Full Text] [Related]
13. [IgG and IgA antibodies to the Epstein-Barr virus and nasopharyngeal carcinoma]. Vera Sempere FJ. Med Clin (Barc); 1992 May 16; 98(19):758-9. PubMed ID: 1318986 [No Abstract] [Full Text] [Related]
14. Nasopharyngeal carcinoma and Epstein-Barr virus--associated serologic markers. Tam JS, Murray HG. Ear Nose Throat J; 1990 Apr 16; 69(4):261-7. PubMed ID: 2161732 [Abstract] [Full Text] [Related]